Security Risks Found in Illumina's DNA Sequencing Machines
The FDA has warned healthcare providers that Illumina's DNA sequencers have a security vulnerability that could allow unauthorized users to access or alter potentially important medical data. This comes at a time when Illumina is facing a proxy battle by Carl Icahn, who is seeking to add three new members to the board and remove CEO Francis deSouza.